Phillip Frost - Mar 19, 2025 Form 4 Insider Report for Fluent, Inc. (FLNT)

Role
10%+ Owner
Signature
/s/ Frost Phillip, M.D., Individually
Stock symbol
FLNT
Transactions as of
Mar 19, 2025
Transactions value $
$1,999,999
Form type
4
Date filed
3/21/2025, 07:33 PM
Previous filing
Mar 17, 2025
Next filing
Mar 28, 2025
SEC
View on sec.gov
This filing has been restated, see here for the amended filing

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FLNT Common Stock Options Exercise $230 +460K +10.51% $0.00 4.84M Mar 20, 2025 Held by Frost Gamma Investments Trust F1
transaction FLNT Common Stock Tax liability -$228 -112 0% $2.04 4.84M Mar 20, 2025 Held by Frost Gamma Investments Trust F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction FLNT Pre-Funded Warrants Award $1M +460K $2.17 460K Mar 19, 2025 Common Stock 460K $0.00 Held by Frost Gamma Investments Trust F1, F2
transaction FLNT Pre-Funded Warrants Options Exercise $1M +460K $2.17 460K Mar 20, 2025 Common Stock 460K $0.00 Held by Frost Gamma Investments Trust F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities are held by Frost Gamma Investments Trust, of which Phillip Frost M.D., is the trustee. Frost Gamma L.P. is the sole and exclusive beneficiary of Frost Gamma Investments Trust. Dr. Frost is one of two limited partners of Frost Gamma L.P. The general partner of Frost Gamma L.P. is Frost Gamma, Inc., and the sole shareholder of Frost Gamma, Inc. is Frost-Nevada Corporation. Dr. Frost is also the sole stockholder of Frost-Nevada Corporation. The reporting persons disclaim beneficial ownership of these securities, except to the extent of any pecuniary interest therein and this report shall not be deemed an admission that any reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.
F2 The Pre-Funded Warrants terminate when exercised in full.
F3 The Pre-Funded Warrants were immediately exercisable when issued. The Pre-Funded Warrants were exercised on March 20, 2025.